Premium
Silencing of long noncoding RNA RP11‐476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA‐138‐5p‐dependent inhibition of LRRK2
Author(s) -
Zhao Yinlong,
Zhao Lingzhi,
Li Junfeng,
Zhong Lili
Publication year - 2019
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.28702
Subject(s) - gene silencing , autophagy , cancer research , microrna , apoptosis , cell growth , transfection , biology , small interfering rna , long non coding rna , microbiology and biotechnology , downregulation and upregulation , ectopic expression , cell culture , gene , genetics
The distant metastasis in papillary thyroid carcinoma (PTC) is a major threat for PTC patients. Moreover, the involvement of long noncoding RNAs (lncRNAs) in the regulation of PTC progression has been extensively investigated. The aim of this study was to underscore whether lncRNA RP11‐476D10.1 affects the proliferation, apoptosis and autophagy of PTC cells. Initially, we determined that lncRNA RP11‐476D10.1 and LRRK2 were highly expressed in PTC cells. Meanwhile, through experimentation, miR‐138‐5p was confirmed to bind with lncRNA RP11‐476D10.1 and LRRK2. It was also revealed that lncRNA RP11‐476D10.1 downregulated the miR‐138‐5p expression, thereby upregulating the LRRK2 expression. After that, PTC cells were transfected with siRNA against RP11‐476D10.1, or inhibitor or mimic of miR‐138‐5p to evaluate the influence of lncRNA RP11‐476D10.1 on the PTC cell proliferation, apoptosis, and autophagy in vitro and on the tumor formation ability in vivo. The results showed that silenced lncRNA RP11‐476D10.1 or overexpressed miR‐138‐5p enhanced the apoptosis and autophagy of PTC cells while reducing cell proliferation, with increased levels of Bax, LC3B, and Beclin1 and decreased Bcl‐2 level were observed. The inhibitory role of silenced lncRNA RP11‐476D10.1 role in the PTC development was further verified by the reduced tumor formation ability in nude mice. Our results demonstrated that lncRNA RP11‐476D10.1 could bind to miR‐138‐5p and promote LRRK2 expression. Moreover, the silencing of lncRNA RP11‐476D10.1 may inhibit the development of PTC, highlighting a novel insight for the development of superior therapeutic targets for PTC treatment.